Recall Register

Food, drugs, devices › Greiner Bio-One North America, Inc.

Device recall: Vacuette Quickshield Complete Plus, 21G x 1 (0.8 x 25 mm), Greiner bio-one. The Quick shield Complete Plus is intended

FDA enforcement event 62447 · Class II · initiated 2 Apr 2012 · status Terminated · terminated 27 Feb 2013

DeviceVoluntary: Firm initiated1 product recordMonroe, NC

Greiner Bio-One North America, Inc. (Monroe, NC) initiated this device recall on 2 Apr 2012; FDA lists 1 product record under event 62447, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 823 device enforcement events initiated in 2012 carry the same class.

Status: Terminated, terminated 27 Feb 2013. Initiation: voluntary: firm initiated. Greiner Bio-One North America, Inc. has 16 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Greiner Bio-One North America, Inc., Monroe, NC.

Reason for recall

": The Quickshield Complete Plus may have a defect (split at the base), which can cause the green safety shield attachment of the Quickshield holder to be loose and unstable."

Distribution

"Nationwide Distribution including IL, MS, OH, PA, TN and VA."

Product records

Recall numberProductQuantityClassStatusReport date
Z-1935-2012Vacuette Quickshield Complete Plus, 21G x 1 (0.8 x 25 mm), Greiner bio-one. The Quick shield Complete Plus is intended to be used only with Vacuette Blood collection Tubes as a system in routine venipuncture procedures. They are for single-use only and should only be used by adequately trained healthcare personnel…19.5 cases (5,850 pieces) and 244 cases (73,200 pieces)= 263.5 (73258 pieces total)Class IITerminated11 Jul 2012

Context

88%of 2012 device events are Class II823 events that year
1product record in this eventfirm median: 1
16events on this register for the firm

Other enforcement events for Greiner Bio-One North America, Inc.

InitiatedProduct (first record)TypeClassRecords
19 Aug 2025Brand Name: Vacuette Product Name: 8 ml CAT Serum Separator Clot Activator Model/Catalog Number: 455071P Product DescripDeviceClass II1
8 Aug 2025Greiner BIO-ONE VACUETTE 2 ml 9NC Coagulation sodium citrate 3.2%, REF: 454322DeviceClass II1
14 May 2024VACUETTE¿ TUBE 8 ml CAT Serum Separator Clot Activator 16x100 red cap-yellow ring, non-ridgedDeviceClass II1
12 Dec 2023VACUETTE TUBE 4 ml FX Sodium Fluoride/Potassium Oxalate, Item #454297, 13x75 grey cap-black ring, non-ridged.DeviceClass II1
31 Mar 2023greiner bio-one VACUETTE TUBE 6 ml K3E K3EDTA, 13x100 pink cap-black ring, non-ridged, 24 racks of 50 pcs., 1200 pcs in DeviceClass II1
9 Dec 2021greiner bio-one VACUETTE TUBE, 5 ml LH Lithium Heparin Sep, 13x100 green cap-yellow ring, non-ridged, 24 racks of 50 pcsDeviceClass II1
20 Aug 2021Greiner Bio-One VACUETTE¿ TUBE 2 ml 9NC Coagulation sodium citrate 3.2% 13x75 blue cap-white ring, sandwich tube, non-riDeviceClass II1
13 Aug 2021VACUETTE TUBE 6 ml K2E K2EDTA 13x100 pink cap-pink ring, non-ridgedDeviceClass II1
29 Mar 2021VACUETTE¿ Blood Collection tube 9NC Coagulation sodium citrate 3.2% 13x75 blue cap-white ring, sandwich tube, non-ridgedDeviceClass II1
28 Aug 2020VACUETTE TUBE 5 mL CAT Serum Separator Clot Activator, Item Number: 456018P - Product Usage: are used to collect, transpDeviceClass II1

All 16 events for Greiner Bio-One North America, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: ": The Quickshield Complete Plus may have a defect (split at the base), which can cause the green safety shield attachment of the Quickshield holder to be loose and unstable."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide Distribution including IL, MS, OH, PA, TN and VA."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 27 Feb 2013. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.